A study on the low-glycemic carbohydrate suggests it may promote more fat utilization for energy than high-glycemic carbohydrates.
A study on Palatinose, the low-glycemic carbohydrate developed by BENEO (Manheim, Germany), suggests that Palatinose may burn more fat than high-glycemic carbohydrates.
When 20 overweight and obese subjects were assigned to breakfast sweetened with Palatinose or a high-glycemic sugar-blend (sucrose and glucose), fat utilization increased with the low-glycemic substitute by approximately 18%. Palatinose appeared to have the effect when subjects were at rest or engaging in physical activity.
The new finding, published in the journal Nutrition, adds to what has already been observed with Palatinose: reduced blood glucose and insulin response after food and drink consumption.
The impact of GLP-1 on supplements, functional foods, and retail: a webinar from CRN
January 29th 2025The recent CRN webinar discussed GLP-1 medications' impact on supplements, functional foods, and retail, covering consumer trends, global market insights, retailer strategies, industry implications, and future opportunities for innovation.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Steve Mister on CRN's ongoing lawsuit against New York State
October 11th 2024Nutritional Outlook spoke to The Council for Responsible Nutrition's president and CEO, Steve Mister, at its annual meeting, Convergence '24. Mister discussed the latest in its ongoing lawsuit against NY State's law banning the sale of weight management and muscle building products to minors.